EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Giant cell tumor of bone: exploring HtrA1 as a potential predictor of recurrence

Akif Mirioglu, Kaan Ali Dalkir, Mehmet Yigit Gokmen, Melih Bagir, Kivilcim Eren Ates, Mehmet Ali Deveci, Gülfiliz Gönlüşen, Hilmi Serdar Ozbarlas

Archives of Orthopaedic and Trauma Surgery · 12.06.2026 · 146 (1)

DOI: 10.1007/s00402-026-06374-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Orthopaedic and Trauma Surgery, online erschienen am 12.06.2026. Verfasst von Akif Mirioglu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics and Traumatology, Cukurova University, Adana, Turkey. akifmirioglu@hotmail.com. Hauptthemen laut MEDLINE: High-Temperature Requirement A Serine Peptidase 1, Giant Cell Tumor of Bone, Neoplasm Recurrence, Local, Bone Neoplasms. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cukurova University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Giant cell tumor of bone (GCTB) is a locally aggressive tumor with a considerable risk of recurrence, but reliable predictive markers are limited. High-temperature requirement A serine peptidase 1 (HtrA1) has been implicated in the progression of several cancers and may also play a role in GCTB recurrence. Materials and methods This retrospective study included 34 patients with GCTB treated with curettage between 2002 and 2016. HtrA1 expression was evaluated separately in giant cells (GC) and mononuclear cells (MNC) using immunohistochemistry. Based on high or low expression in each cell type, patients were categorized into four expression patterns: High GC / High MNC, High GC / Low MNC, Low GC / High MNC, and Low GC / Low MNC. Clinical data, including recurrence status and time to recurrence, were analyzed.

Results

The High GC / Low MNC group showed the highest recurrence rate at 71.4%, compared with 28.6% in the High GC / High MNC group and 31.6% in the Low GC / Low MNC group. No recurrence was observed in the Low GC / High MNC group, which included only one patient. The High GC / Low MNC group showed a non-significant trend toward higher recurrence compared with all other groups combined, with a similar trend toward shorter recurrence-free survival.

Conclusion

HtrA1 expression patterns in GCTB may provide preliminary insight into recurrence risk. Although no statistically significant association was demonstrated, the observed trends suggest potential prognostic relevance and warrant validation in larger cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

High-Temperature Requirement A Serine Peptidase 1Giant Cell Tumor of BoneNeoplasm Recurrence, LocalBone NeoplasmsHumansFemaleRetrospective StudiesMaleAdultMiddle AgedBiomarkers, TumorImmunohistochemistryYoung AdultPrognosisAdolescent

Stichwörter der Autor:innen

Giant cell tumor of boneHigh-temperature requirement A serine peptidase 1ImmunohistochemistryPrognosis

Substanzen

High-Temperature Requirement A Serine Peptidase 1HTRA1 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Orthopaedics and Traumatology, Cukurova University, Adana, Turkey. akifmirioglu@hotmail.com.
  • Department of Orthopaedics and Traumatology, Cukurova University, Adana, Turkey. kali.dalkir@hotmail.com.
  • Department of Orthopaedics and Traumatology, Çanakkale Onsekiz Mart University, Çanakkale, Turkey.
  • Department of Orthopaedics and Traumatology, Cukurova University, Adana, Turkey.
  • Department of Pathology, Cukurova University, Adana, Turkey.
  • Department of Orthopaedics and Traumatology, Koç University, Istanbul, Turkey.

Förderung

  • Cukurova University

Zitieren

APA

Mirioglu, A., Dalkir, K. A., Gokmen, M. Y., Bagir, M., Ates, K. E., Deveci, M. A., Gönlüşen, G., & Ozbarlas, H. S. (2026). Giant cell tumor of bone: exploring HtrA1 as a potential predictor of recurrence. Archives of Orthopaedic and Trauma Surgery, 146(1). https://doi.org/10.1007/s00402-026-06374-5

Vancouver

Mirioglu A, Dalkir KA, Gokmen MY, Bagir M, Ates KE, Deveci MA, et al. Giant cell tumor of bone: exploring HtrA1 as a potential predictor of recurrence. Archives of Orthopaedic and Trauma Surgery. 2026;146(1). doi:10.1007/s00402-026-06374-5

BibTeX
@article{Mirioglu2026,
  author = {Mirioglu, Akif and Dalkir, Kaan Ali and Gokmen, Mehmet Yigit and Bagir, Melih and Ates, Kivilcim Eren and Deveci, Mehmet Ali and Gönlüşen, Gülfiliz and Ozbarlas, Hilmi Serdar},
  title = {Giant cell tumor of bone: exploring HtrA1 as a potential predictor of recurrence},
  journal = {Archives of Orthopaedic and Trauma Surgery},
  year = {2026},
  volume = {146},
  number = {1},
  doi = {10.1007/s00402-026-06374-5}
}
Kostenlos starten →